TRIAMCINOLONE ACETONIDE cream

البلد: الولايات المتحدة

اللغة: الإنجليزية

المصدر: NLM (National Library of Medicine)

اشتر الآن

تأكيد الحساب خصائص المنتج (SPC)
07-08-2018

العنصر النشط:

TRIAMCINOLONE ACETONIDE (UNII: F446C597KA) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA)

متاح من:

DIRECT RX

طريقة التعاطي:

TOPICAL

نوع الوصفة الطبية :

PRESCRIPTION DRUG

الخصائص العلاجية:

- Triamcinolone acetonide cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

ملخص المنتج:

Triamcinolone Acetonide Cream USP, 0.025% Triamcinolone Acetonide Cream USP, 0.1% 15 gram tubes NDC 0168-0003-15 15 gram tubes NDC 0168-0004-15 80 gram tubes NDC 0168-0003-80 80 gram tubes NDC 0168-0004-80 1 Lb jars NDC 0168-0004-16 Triamcinolone Acetonide Cream USP, 0.5% 15 gram tubes NDC 0168-0002-15. Store at controlled room temperature 15°-30°C (59°-86°F). Avoid excessive heat. Protect from freezing. Fougera PHARMACEUTICALS INC. E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. Melville New York 11747 I20215G/IF20215G R09/11 #227 46165001A R06/15 #65

الوضع إذن:

Abbreviated New Drug Application

خصائص المنتج

                                TRIAMCINOLONE ACETONIDE- TRIAMCINOLONE ACETONIDE CREAM
DIRECT RX
----------
TRIAMCINOLONE ACETONIDE 0.1% 30G
Triamcinolone acetonide cream is contraindicated in those patients
with a history of hypersensitivity to
any of the components of the preparation.
Topically applied corticosteroids can be absorbed in sufficient
amounts to produce systemic effects
(See PRECAUTIONS).
Apply to the affected area as a thin film as follows: Triamcinolone
Acetonide Cream USP, 0.025% two
to four times daily; Triamcinolone Acetonide Cream USP, 0.1% and 0.5%
two or three times daily
depending on the severity of the condition. Occlusive dressings may be
used for the management of
psoriasis or recalcitrant conditions. If an infection develops, the
use of occlusive dressings should be
discontinued and appropriate antimicrobial therapy instituted.
Triamcinolone Acetonide Cream USP, 0.025%
Triamcinolone Acetonide Cream USP, 0.1%
15 gram tubes NDC 0168-0003-15
15 gram tubes NDC 0168-0004-15
80 gram tubes NDC 0168-0003-80
80 gram tubes NDC 0168-0004-80
1 Lb jars NDC 0168-0004-16
Triamcinolone Acetonide Cream USP, 0.5%
15 gram tubes NDC 0168-0002-15.
Store at controlled room temperature 15°-30°C (59°-86°F).
Avoid excessive heat. Protect from freezing.
Fougera
PHARMACEUTICALS INC.
E. FOUGERA & CO.
A division of Fougera Pharmaceuticals Inc.
Melville New York 11747
I20215G/IF20215G
R09/11
#227
46165001A
R06/15
#65
The following local adverse reactions are reported infrequently with
topical corticosteroids, but may
occur more frequently with the use of occlusive dressings. These
reactions are listed in an approximate
decreasing order of occurrence: burning, itching, irritation, dryness,
folliculitis, hypertrichosis,
acneiform eruptions, hypopigmentation, perioral dermatitis, allergic
contact dermatitis, maceration of
the skin, secondary infection, skin atrophy, striae and miliaria.
To report suspected adverse reactions1-888-463-6332
Rx only
Triamcinolone Acetonide Cream USP contains Triamcinolone Acetonide
[Pregna-1,4-diene-3,20-dione,
9-fl
                                
                                اقرأ الوثيقة كاملة
                                
                            

تنبيهات البحث المتعلقة بهذا المنتج

عرض محفوظات المستندات